Purpose
To assess the effect of amiodarone on the risk of resuscitated ventricular fibrillation or arrhythmic death among survivors of
myocardial infarction with > 10 VPDs/h or > 1 run of ventricular tachycardia
References
Cairns JA, Connolly SJ, Roberts R, Gent M on behalf of CAMIAT Investigators: Canadian Amiodarone Myocardial Infarction
Arrhythmia Trial (CAMIAT): rationale and protocol. Am J Cardiol 1993, 72:87F-93F.
Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators:
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature
depolarisations: CAMIAT. Lancet 1997, 349:675-682. |
Farmacêutica